-
Vertex reports long-term results for Casgevy in sickle cell and thalassaemia
04 Jul 2025 21:50 GMT
Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued … communities with significant unmet need.”
Vertex’s Casgevy is the first … therapies promised to revolutionise the pharmaceutical industry, the uptake has been …
-
Pharmaceuticals and Biotechnology Manufacturing and Supply Agreement Trends Analysis Report and Directory 2020-2025 - ResearchAndMarkets.com
04 Jul 2025 20:11 GMT
…
Hitachi Chemical
ImmunoGen
Incyte
Ionis Pharmaceuticals
Janssen Pharmaceuticals
Laboratory Corporation of America …
Roche
Sanofi
Sinovac Biotech
Takeda Pharmaceutical
Vaccibody
Vertex Pharmaceuticals
For more information about …
-
Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Agreement Trends Analysis Report 2025 with Directory of Deals by Company A-Z, Therapy Focus and Technology Type - ResearchAndMarkets.com
02 Jul 2025 12:19 GMT
…
Allegis Pharmaceuticals
Alnylam Pharmaceuticals
Amneal Pharmaceuticals
Apellis Pharmaceuticals
Arcus Biosciences
Arrowhead Pharmaceuticals
Assembly … Sutro Biopharma
Takeda Pharmaceutical
Thermo Fisher Scientific
UCB
Vertex Pharmaceuticals
For more …
-
Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold
02 Jul 2025 10:50 GMT
Vertex Pharmaceuticals has won approval in …
Analysis by GlobalData’s Pharma Intelligence Centre forecasts Alyftrek will … The pharma company has a market cap of $116bn.
Vertex’s … our leading industry insights.
Pharmaceutical Technology Excellence Awards - Have …
-
Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis
02 Jul 2025 05:27 GMT
… -
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced … and New Zealand.
About Vertex
Vertex is a global biotechnology company … available.
(VRTX-GEN)
Contacts
Vertex Pharmaceuticals Incorporated
Investors:
InvestorInfo@vrtx.com …
-
Sodium channel blockers for pain: New opportunities after Vertex’s ‘watershed’ moment
01 Jul 2025 13:23 GMT
… attributed, in good part, to Vertex Pharmaceuticals, which has led the charge … pain, Journavx.
Permission granted by Vertex Pharmaceuticals
What are sodium channel inhibitors … of pain
Stage of development
Vertex Pharmaceuticals
suzetrigine
NaV1.8 / …
-
Repertory-Guided Homeopathic Management of Androgenetic Alopecia: An Individualized Approach to a Common Trichological Disorder
04 Jul 2025 19:03 GMT
… are affected preferentially: temples, vertex scalp, and mid-frontal … frontal hairline, temples, and vertex only minimally affected. This … at the temples.
∙ Vertex balding: Thinning at the crown … alopecia. Expert Opinion on Pharmacotherapy, 11(8), 1295–1304. …
-
Global Anti-Inflammatory Drugs Market Forecast To Reach $228.83 Billion By 2029 With 10.8% Annual Growth
04 Jul 2025 17:39 GMT
… Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB … S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma … Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Moreover, it …
-
β-Thalassemia Gene Therapy in the Context of the Broader World
03 Jul 2025 17:29 GMT
… reinfusion into the patient, and Vertex Pharmaceuticals and CRISPR Therapeutics’ exagamglogene autotemcel … &utm_source=govdelivery
3. Vertex Announces US FDA Approval of … /news-release-details/vertex-announces-us-fda-approval-casgevytm …
-
Islet Cell Therapy Has Potential to Cure Type 1 Diabetes
02 Jul 2025 21:31 GMT
… 1 diabetes who have received Vertex Pharmaceuticals’ zimislecel and with at least … people with Type 1 diabetes.
Vertex officials estimate that about 125 … rejection of the islet cells.
Vertex expects to complete enrollment and …
About
© 1995-2025